{"title_page": "Harderoporphyria", "text_new": "{{Infobox medical condition (new)\n| name            = Harderoporphyria\n| synonyms        = \n| image           = Coproporphyrinogen III.svg\n| caption         = [[Coproporphyrinogen III]]\n| pronounce       = \n| field           = \n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n\n'''Harderoporphyria''' is a rare disorder of [[heme]] biosynthesis, inherited in an [[autosomal recessive]] manner caused by specific mutations in the ''CPOX'' gene.  Mutations in ''CPOX'' usually cause [[hereditary coproporphyria]], an acute hepatic [[porphyria]], however the K404E mutation in a homozygous or compound heterozygous state with a [[null allele]] cause the more severe harderoporphyria.<ref name=harderoreview>{{Cite journal | last1 = Schmitt | first1 = C. | last2 = Gouya | first2 = L. | last3 = Malonova | first3 = E. | last4 = Lamoril | first4 = J. | last5 = Camadro | first5 = J. M. | last6 = Flamme | first6 = M. | last7 = Rose | first7 = C. | last8 = Lyoumi | first8 = S. | last9 = Da Silva | first9 = V. | last10 = Boileau | first10 = C. | last11 = Grandchamp | first11 = B. | last12 = Beaumont | first12 = C. | last13 = Deybach | first13 = J. C. | last14 = Puy | first14 = H. | title = Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria | doi = 10.1093/hmg/ddi342 | journal = Human Molecular Genetics | volume = 14 | issue = 20 | pages = 3089\u20133098 | year = 2005 | pmid = 16159891 | pmc = }}</ref>  Harderoporphyria is the first known metabolic disorder where the disease [[phenotype]] depended on the type and location of the mutations in a gene associated with multiple disorders.<ref name=omim />\n\nIn contrast with other porphyrias, which typically present with either cutaneous lesions after exposure to sunlight or acute neurovisceral attack at any age (most commonly in adulthood), harderoporphyria is characterized by [[jaundice]], [[anemia]] enlarged liver and [[spleen]], often presenting in the neonatal period.  Later in life, these individuals may present with photosensitivity similar to that found in [[cutaneous porphyria]]s.<ref name=omim>{{cite web|title= #121300 COPROPORPHYRIA, HEREDITARY; HCP|url=http://omim.org/entry/121300|accessdate=2012-05-27|publisher=Johns Hopkins University}}</ref>\n\nBiochemically, harderoporphyria presents with a distinct pattern of increased harderoporphyrin (2-vinyl-4,6,7-tripropionic acid porphyrin)<ref>{{cite journal|last1=Gorchein|first1=A.|last2=Danton|first2=M.|last3=Lim|first3=C. K.|title=Harderoporphyrin: a misnomer|journal=Biomedical Chromatography |pages=565\u2013569|doi=10.1002/bmc.480|date=October 2005|pmid=15678522|volume=19|issue=8}}</ref> in [[urine]] and particularly in [[feces]], a metabolite that is not seen in significant quantities in any other porphyria.<ref name=omim />  Enzyme tests show markedly reduced activity of [[coproporphyrinogen oxidase]], compared to both unaffected individuals and those affected with hereditary coproporphyria, consistent with recessive inheritance.<ref name=omim />\n\nHarderoporphyria is a rare condition, with less than 10 cases reported worldwide.  It may be underdiagnosed, as it does not have the typical presentation associated with a porphyria.<ref name=omim />  It was identified as a variant type of coproporphyria in 1983, in a family with three children identified at birth with jaundice and hemolytic anemia.<ref name=disc>{{Cite journal | last1 = Nordmann | first1 = Y. | last2 = Grandchamp | first2 = B. | last3 = De Verneuil | first3 = H. | last4 = Phung | first4 = L. | last5 = Cartigny | first5 = B. | last6 = Fontaine | first6 = G. | doi = 10.1172/JCI111039 | title = Harderoporphyria: A variant hereditary coproporphyria | journal = Journal of Clinical Investigation | volume = 72 | issue = 3 | pages = 1139\u20131149 | year = 1983 | pmid = 6886003 | pmc =1129282 }}</ref>  There is no standard treatment for harderoporphyria; care is mainly focused on the management of symptoms.<ref name=disc /><ref name=blood>{{Cite journal | last1 = Lamoril | first1 = J. | last2 = Puy | first2 = H. | last3 = Gouya | first3 = L. | last4 = Rosipal | first4 = R. | last5 = Da Silva | first5 = V. | last6 = Grandchamp | first6 = B. | last7 = Foint | first7 = T. | last8 = Bader-Meunier | first8 = B. | last9 = Dommergues | first9 = J. P. | last10 = Deybach | first10 = J. C. | last11 = Nordmann | first11 = Y. | title = Neonatal hemolytic anemia due to inherited harderoporphyria: Clinical characteristics and molecular basis | journal = Blood | volume = 91 | issue = 4 | pages = 1453\u20131457 | year = 1998 | pmid = 9454777}}</ref>\n\n==References==\n{{reflist}}\n== External links ==\n{{Medical resources\n| DiseasesDB      = \n| ICD10           = \n| ICD9            = \n| ICDO            = \n| OMIM            = 121300\n| MedlinePlus     = \n| eMedicineSubj   = \n| eMedicineTopic  = \n| MeshID          = C562816\n| SNOMED CT       = 238056003\n}}\n{{Heme metabolism disorders}}\n\n[[Category:Porphyrias]]\n[[Category:Heme metabolism disorders]]\n", "text_old": "{{Infobox medical condition (new)\n| name            = Harderoporphyria\n| synonyms        = \n| image           = Coproporphyrinogen III.svg\n| caption         = [[Coproporphyrinogen III]]\n| pronounce       = \n| field           = \n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n\n'''Harderoporphyria''' is a rare disorder of [[heme]] biosynthesis, inherited in an [[autosomal recessive]] manner caused by specific mutations in the ''CPOX'' gene.  Mutations in ''CPOX'' usually cause [[hereditary coproporphyria]], an acute hepatic [[porphyria]], however the K404E mutation in a homozygous or compound heterozygous state with a [[null allele]] cause the more severe harderoporphyria.<ref name=harderoreview>{{Cite journal | last1 = Schmitt | first1 = C. | last2 = Gouya | first2 = L. | last3 = Malonova | first3 = E. | last4 = Lamoril | first4 = J. | last5 = Camadro | first5 = J. M. | last6 = Flamme | first6 = M. | last7 = Rose | first7 = C. | last8 = Lyoumi | first8 = S. | last9 = Da Silva | first9 = V. | last10 = Boileau | first10 = C. | last11 = Grandchamp | first11 = B. | last12 = Beaumont | first12 = C. | last13 = Deybach | first13 = J. C. | last14 = Puy | first14 = H. | title = Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria | doi = 10.1093/hmg/ddi342 | journal = Human Molecular Genetics | volume = 14 | issue = 20 | pages = 3089\u20133098 | year = 2005 | pmid = 16159891 | pmc = }}</ref>  Harderoporphyria is the first known metabolic disorder where the disease [[phenotype]] depended on the type and location of the mutations in a gene associated with multiple disorders.<ref name=omim />\n\nIn contrast with other porphyrias, which typically present with either cutaneous lesions after exposure to sunlight or acute neurovisceral attack at any age (most commonly in adulthood), harderoporphyria is characterized by [[jaundice]], [[anemia]] enlarged liver and [[spleen]], often presenting in the neonatal period.  Later in life, these individuals may present with photosensitivity similar to that found in [[cutaneous porphyria]]s.<ref name=omim>{{cite web|title= #121300 COPROPORPHYRIA, HEREDITARY; HCP|url=http://omim.org/entry/121300|accessdate=2012-05-27|publisher=Johns Hopkins University}}</ref>\n\nBiochemically, harderoporphyria presents with a distinct pattern of increased harderoporphyrin (2-vinyl-4,6,7-tripropionic acid porphyrin)<ref>{{cite journal|last1=Gorchein|first1=A.|last2=Danton|first2=M.|last3=Lim|first3=C. K.|title=Harderoporphyrin: a misnomer|journal=Biomedical Chromatography |pages=565\u2013569|doi=10.1002/bmc.480|date=October 2005|pmid=15678522|volume=19|issue=8}}</ref> in [[urine]] and particularly in [[feces]], a metabolite that is not seen in significant quantities in any other porphyria.<ref name=omim />  Enzyme tests show markedly reduced activity of [[coproporphyrinogen oxidase]], compared to both unaffected individuals and those affected with hereditary coproporphyria, consistent with recessive inheritance.<ref name=omim />\n\nHarderoporphyria is a rare condition, with less than 10 cases reported worldwide.  It may be underdiagnosed, as it does not have the typical presentation associated with a porphyria.<ref name=omim />  It was identified as a variant type of coproporphyria in 1983, in a family with three children identified at birth with jaundice and hemolytic anemia.<ref name=disc>{{Cite journal | last1 = Nordmann | first1 = Y. | last2 = Grandchamp | first2 = B. | last3 = De Verneuil | first3 = H. | last4 = Phung | first4 = L. | last5 = Cartigny | first5 = B. | last6 = Fontaine | first6 = G. | doi = 10.1172/JCI111039 | title = Harderoporphyria: A variant hereditary coproporphyria | journal = Journal of Clinical Investigation | volume = 72 | issue = 3 | pages = 1139\u20131149 | year = 1983 | pmid = 6886003 | pmc =1129282 }}</ref>  There is no standard treatment for harderoporphyria; care is mainly focused on the management of symptoms.<ref name=disc /><ref name=blood>{{Cite journal | last1 = Lamoril | first1 = J. | last2 = Puy | first2 = H. | last3 = Gouya | first3 = L. | last4 = Rosipal | first4 = R. | last5 = Da Silva | first5 = V. | last6 = Grandchamp | first6 = B. | last7 = Foint | first7 = T. | last8 = Bader-Meunier | first8 = B. | last9 = Dommergues | first9 = J. P. | last10 = Deybach | first10 = J. C. | last11 = Nordmann | first11 = Y. | title = Neonatal hemolytic anemia due to inherited harderoporphyria: Clinical characteristics and molecular basis | journal = Blood | volume = 91 | issue = 4 | pages = 1453\u20131457 | year = 1998 | pmid = 9454777}}</ref>\n\n==References==\n{{reflist}}\n== External links ==\n{{Medical resources\n|  DiseasesDB      = \n|  ICD10           =  \n|  ICD9            =  \n|  ICDO            =  \n|  OMIM            = 121300  \n|  MedlinePlus     =  \n|  eMedicineSubj   =  \n|  eMedicineTopic  =  \n|  MeshID          = \n}}\n{{Heme metabolism disorders}}\n\n[[Category:Porphyrias]]\n[[Category:Heme metabolism disorders]]\n", "name_user": "Dismanet", "label": "safe", "comment": "Adding new medical resources.", "url_page": "//en.wikipedia.org/wiki/Harderoporphyria"}
